Thursday, March 05, 2009

B - Preserving Intellectual Freedom in Clinical Medicine

Fava GA. Preserving Intellectual Freedom in Clinical Medicine. Psychotherapy and Psychosomatics. 2009;78:1-5
DOI: 10.1159/000162295


http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowFulltext&ArtikelNr=162295&Ausgabe=240438&ProduktNr=223864


The paper, authored by the journal editor, notes that the drug industry has full control of many scientific societies, journals and clinical practice guidelines. Members of special interest groups act as editors, reviewers and consultants to medical journals, scientific meetings and non-profit research organisations, with the task of systematically preventing the dissemination of data which may be in conflict with their interest. It further states that censorship may be the result of direct prevention of publication and dissemination of findings by the pharmaceutical company itself. The paper provides several suggestions for preserving intellectual freedom in medicine, based on research evidence which is available.

Thanks to Emma Campbell

No comments: